<DOC>
	<DOCNO>NCT01851902</DOCNO>
	<brief_summary>The purpose study determine , continuous monitoring cardiac monitoring device place skin , incidence atrial fibrillation flutter ( AF ) . The cardiac monitor place patient without symptom risk AF . It hop information may assist health care professional treatment decision relate early identification patient high risk AF .</brief_summary>
	<brief_title>PREdicting Atrial Fibrillation Flutter</brief_title>
	<detailed_description>Background : Atrial fibrillation atrial flutter ( AF ) common cardiac arrhythmia confer substantial stroke burden largely vast majority AF asymptomatic identify stroke occur . Until recently , intermittent cardiac monitor available , AF episodes remain undetected due poor sensitivity . Health care provider estimate risk stroke AF patient use patient 's comorbidity profile determine treat oral anticoagulant therapy stroke prevention . The incidence AF patient high stroke risk comorbidities know . The Medtronic Reveal insertable cardiac monitor ( ICM ) continuous monitoring device excellent AF detection . Purpose Study Objectives : The purpose PREDATE AF study determine incidence AF asymptomatic patient high risk AF order determine patient characteristic predictive development AF . The primary objective determine AF incidence rate ; secondary objective include identify important predictor AF onset identify physician respond AF discover . Study Design : The trial prospective , single arm , open-label , single center clinical study enroll 360 patient high risk AF base upon comorbidity profile , receive ICM . Enrolled subject follow minimum 18 month monitor detection AF . Monthly ICM data transmission mechanism AF detection , information utilized determine AF incidence rate</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Atrial Flutter</mesh_term>
	<criteria>Patient meet approve FDA indication receive ICM Patient suspect , base demographic , high risk AF , determine clinical investigator Patient CHA2DS2VASc score â‰¥ 2 [ Note : stroke/TIA criterion part CHA2DS2VASc score trial limit either ischemic stroke TIA , occur one year prior enrollment . ] Patient 18 year age old Patient life expectancy 18 month Patient document history AF atrial flutter Patient symptom complex consistent arrhythmia ( ICM may alternate indication use ) Patient ischemic stroke TIA within past year prior enrollment Patient history hemorrhagic stroke Patient currently implant permanent pacemaker , insertable loop recorder , implantable defibrillator , cardiac resynchronization therapy device ( pacemaker defibrillator ) NYHA Class IV Heart Failure patient Patient heart surgery within previous 90 day prior enrollment Patient MI within previous 90 day prior enrollment Patient take chronic immunosuppressant therapy Patient take antiarrhythmic drug Patient contraindicate long term anticoagulation medication Patient take longterm anticoagulation medication Any concomitant condition , opinion investigator , would allow safe participation study ( e.g. , drug addiction , alcohol abuse , emotional / psychological diagnosis ) Patient enrol another study could confound result study , without document preapproval principal investigator Patient creatinine clearance &lt; 30 ml/min dialysis Active pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Atrial Flutter</keyword>
	<keyword>Arrhythmia</keyword>
</DOC>